<p>IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma</p>
Cited by 53
Related Papers
Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway
|British Journal of Cancer|2014|108
Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling
|British Journal of Cancer|2017|30
<p>Secretory Pathway Kinase <em>FAM20C</em>, a Marker for Glioma Invasion and Malignancy, Predicts Poor Prognosis of Glioma</p>
|OncoTargets and Therapy|2020|16
Molecular profiling identifies distinct subtypes across TP53 mutant tumors
|JCI Insight|2022|9